<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101573691</journal-id>
<journal-id journal-id-type="pubmed-jr-id">39703</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
<journal-title-group>
<journal-title>Cell reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2211-1247</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28746872</article-id>
<article-id pub-id-type="pmc">5603761</article-id>
<article-id pub-id-type="doi">10.1016/j.celrep.2017.07.008</article-id>
<article-id pub-id-type="manuscript">NIHMS892234</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lipton</surname>
<given-names>Jonathan O.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boyle</surname>
<given-names>Lara M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Elizabeth D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hochstrasser</surname>
<given-names>Kevin J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chifamba</surname>
<given-names>Fortunate F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nathan</surname>
<given-names>Ashwin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsai</surname>
<given-names>Peter T.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Fred</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Mustafa</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">5</xref>
<xref ref-type="author-notes" rid="FN2">6</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Neurology, F.M. Kirby Neurobiology Center, Boston Childrenâ€™s Hospital, Boston MA</aff>
<aff id="A2">
<label>2</label>Division of Sleep Medicine, Harvard Medical School, Boston, MA</aff>
<aff id="A3">
<label>3</label>Department of Neurology and Neurotherapeutics, University of Texas at Southwestern, Dallas, TX</aff>
<aff id="A4">
<label>4</label>Department of Biology, Northeastern University, Boston, MA</aff>
<author-notes>
<corresp id="FN1"><label>5</label>To whom correspondence should be addressed: <email>Mustafa.sahin@childrens.harvard.edu</email>, <email>jonathan.lipton@childrens.harvard.edu</email></corresp>
<fn id="FN2">
<label>6</label>
<p>Lead contact</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>25</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>20</volume>
<issue>4</issue>
<fpage>868</fpage>
<lpage>880</lpage>
<!--elocation-id from pubmed: 10.1016/j.celrep.2017.07.008-->
<abstract id="Abs1">
<title>SUMMARY</title>
<p id="P1">Tuberous Sclerosis Complex (TSC) is a neurodevelopmental disorder characterized by mutations in either the <italic>TSC1</italic> or <italic>TSC2</italic> genes whose products form a critical inhibitor of the mechanistic target of rapamycin (mTOR). Loss of <italic>TSC1/2</italic> gene function renders an mTOR-overactivated state. Clinically, TSC manifests with epilepsy, intellectual disability, autism, and sleep dysfunction. Here we report that mouse models of TSC have abnormal circadian rhythms. We show that mTOR regulates the proteostasis of the core clock protein BMAL1, affecting its translation, degradation, and subcellular localization. This results in elevated levels of BMAL1 and a dysfunctional clock that displays abnormal timekeeping in constant conditions and exaggerated responses to phase resetting. Genetically lowering the dose of BMAL1 rescues circadian behavioral phenotypes in TSC mouse models. These findings indicate that BMAL1 deregulation is a feature of the mTOR-activated state and suggest a molecular mechanism for mitigating circadian phenotypes in a neurodevelopmental disorder.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>eTOC Blurb</title>
<p id="P2">Sleep disorders are common in neurodevelopmental disorders such as the Tuberous Sclerosis Complex (TSC). Lipton <italic>et al.</italic> demonstrate that increased translation and decreased degradation of the core clock protein BMAL1 underlie circadian rhythm abnormalities in TSC mouse and cellular models.</p>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms892234u1.jpg"></graphic></p>
</abstract>
<kwd-group>
<kwd>Tuberous Sclerosis Complex</kwd>
<kwd>circadian rhythms</kwd>
<kwd>BMAL1</kwd>
<kwd>translation</kwd>
<kwd>neurodevelopmental disorder</kwd>
<kwd>mTOR</kwd>
<kwd>sleep disorders</kwd>
<kwd>autism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>